147 related articles for article (PubMed ID: 38311175)
21. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells.
Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q
Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822
[TBL] [Abstract][Full Text] [Related]
22. FUT11 is a target gene of HIF1α that promotes the progression of hepatocellular carcinoma.
Ruan W; Yang Y; Yu Q; Huang T; Wang Y; Hua L; Zeng Z; Pan R
Cell Biol Int; 2021 Nov; 45(11):2275-2286. PubMed ID: 34288238
[TBL] [Abstract][Full Text] [Related]
23. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia inducible factors in hepatocellular carcinoma.
Chen C; Lou T
Oncotarget; 2017 Jul; 8(28):46691-46703. PubMed ID: 28493839
[TBL] [Abstract][Full Text] [Related]
25. Histone H3 activates caspase-1 and promotes proliferation and metastasis in hepatocellular carcinoma.
Jing M; Qiong L; Wang Z; Xiong X; Fu Y; Yan W
Int J Med Sci; 2023; 20(5):689-701. PubMed ID: 37082731
[No Abstract] [Full Text] [Related]
26. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.
Dai Q; Yin Q; Wei L; Zhou Y; Qiao C; Guo Y; Wang X; Ma S; Lu N
Mol Carcinog; 2016 Aug; 55(8):1275-89. PubMed ID: 26259145
[TBL] [Abstract][Full Text] [Related]
27. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2.
Lee NO; Park JW; Lee JA; Shim JH; Kong SY; Kim KT; Lee YS
J Cancer Res Clin Oncol; 2012 Jan; 138(1):73-84. PubMed ID: 22009181
[TBL] [Abstract][Full Text] [Related]
28. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
29. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
Cheng S; Zhang X; Xu Y; Dai X; Li J; Zhang T; Chen X
Sci Rep; 2018 Nov; 8(1):17415. PubMed ID: 30479372
[TBL] [Abstract][Full Text] [Related]
30. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.
Husain A; Chiu YT; Sze KM; Ho DW; Tsui YM; Suarez EMS; Zhang VX; Chan LK; Lee E; Lee JM; Cheung TT; Wong CC; Chung CY; Ng IO
J Hepatol; 2022 Aug; 77(2):383-396. PubMed ID: 35227773
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
Lin D; Wu J
World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
[TBL] [Abstract][Full Text] [Related]
33. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells.
Tak E; Jun DY; Kim SH; Park GC; Lee J; Hwang S; Song GW; Lee SG
J Int Med Res; 2016 Dec; 44(6):1234-1247. PubMed ID: 27807254
[TBL] [Abstract][Full Text] [Related]
36. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
37. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces genomic DNA demethylation through the activation of HIF-1α and transcriptional upregulation of MAT2A in hepatoma cells.
Liu Q; Liu L; Zhao Y; Zhang J; Wang D; Chen J; He Y; Wu J; Zhang Z; Liu Z
Mol Cancer Ther; 2011 Jun; 10(6):1113-23. PubMed ID: 21460102
[TBL] [Abstract][Full Text] [Related]
39. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
40. Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration.
Schnabl B; Valletta D; Kirovski G; Hellerbrand C
Exp Mol Pathol; 2011 Dec; 91(3):695-701. PubMed ID: 21840307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
